Research

A monoclonal antibody cocktail against the COVID-19 virus discovered at VUMC is the first non-vaccine modified to demonstrate the prevention of COVID-19 in a clinical trial of more than 5,000 participants. The antibody treatment could afford up to 12 months of protection from COVID-19, and preliminary laboratory findings also suggest that it can neutralize the delta variant. Read More

Vanderbilt researchers have discovered a potential way to reduce atherosclerosis: blocking the modification of an HDL-associated enzyme by reactive molecules called isolevuglandins. Read More

Music Row becomes Technology Row The School of Engineering has created two new departments from the Department of Electrical Engineering and Computer Science to encourage innovation, accommodate enrollment growth, and focus on areas of strategic excellence. The existing degree programs in computer science will be housed in the new Department of Computer Science chaired by... Read More

In a randomized controlled trial, vitamin D supplementation did not improve biomarkers for cardiovascular and metabolic disease. Read More

Vanderbilt neurologists found altered excitability in deep brain structures that they note may drive respiratory dysfunction and sudden death in a rare form of epilepsy. Read More

The motor protein MYO5B, a cause of the congenital intestinal disorder microvillus inclusion disease, does more than move cellular cargo, Vanderbilt researchers have discovered. Read More

Vanderbilt researchers are looking to mRNA populations in podocytes — kidney cells that help filter blood — to help identify potential targets for treating diabetic kidney disease. Read More

Chemoresistant SW480 colon cancer cells stained for lipid rafts (green), death receptor 4 (red) and cell nuclei (blue). Image taken by Joshua Greenlee using a Zeiss LSM 880 from the Vanderbilt Cell Imaging Shared Resource Center. By Marissa Shapiro THE IDEA Vanderbilt faculty and researchers are looking for the “Achilles’ heel” of the cancer cells... Read More

Chemoresistant SW480 colon cancer cells stained for lipid rafts (green), death receptor 4 (red) and cell nuclei (blue). Image taken by Joshua Greenlee using a Zeiss LSM 880 from the Vanderbilt Cell Imaging Shared Resource Center. By Marissa Shapiro THE IDEA Vanderbilt faculty and researchers are looking for the “Achilles’ heel” of the cancer cells... Read More

Vanderbilt researchers developed new prognostic models for breast cancer outcomes and found that adding postdiagnostic weight change as a factor improves the prediction. Read More

Three ambitious, multidisciplinary projects led by Vanderbilt School of Engineering faculty will be featured Wednesday and Thursday, July 28 and 29, during the NSF Convergence Accelerator Expo 2021. The two-day virtual event will present 15-minute demonstrations of novel solutions that address big-scale societal challenges. The NSF-funded projects integrate disciplines and include industry partners from their... Read More

Three ambitious, multidisciplinary projects led by Vanderbilt School of Engineering faculty will be featured Wednesday, July 28, and Thursday, July 29, during the National Science Foundation Convergence Accelerator Expo 2021. Read More

Validation of cognitive complaints appears to improve mood in patients with persistent chemotherapy-cognitive impairment, Vanderbilt researchers report. Read More

Vanderbilt biochemists have discovered that the protein RADX has different biological effects at sites of DNA synthesis, depending on the cellular conditions — even though it works the same way in both stressed and unstressed cells. Read More

Large-scale studies will be required to identify the complexity of genetic variations that affect how patients respond to a given drug and whether they will have side effects, according to researchers at Vanderbilt University Medical Center. Read More

Hospital data from a CDC network that monitors influenza revealed that adults hospitalized for COVID-19 in the early months of the pandemic were 20x more likely to die compared to hospitalized influenza patients. Read More

A U.S. Department of Energy $4 million initiative to advance research in isotope production includes a Vanderbilt engineering professor’s work on separation technologies and to scale up processes. The funding is part of a key federal program that produces critical isotopes otherwise unavailable or in short supply for U.S. science, medicine and industry. Piran Kidambi,... Read More

A U.S. Department of Energy $4 million initiative to advance research in isotope production includes a Vanderbilt engineering professor’s work on separation technologies and to scale up processes. The funding is part of a key federal program that produces critical isotopes otherwise unavailable or in short supply for U.S. science, medicine and industry. Piran Kidambi,... Read More

A new, $1.5 million Department of Energy grant brings together experts from three institutions to parse the metabolism of a blue-green algae that holds great promise for biofuel production. The team, led by Professor of Chemical and Biomolecular Engineering Jamey Young, will take a systems biology approach to identify how cyanobacteria, also known as blue-green... Read More

A new, $1.5 million Department of Energy grant brings together experts from three institutions to parse the metabolism of a blue-green algae that holds great promise for biofuel production. The team, led by Professor of Chemical and Biomolecular Engineering Jamey Young, will take a systems biology approach to identify how cyanobacteria, also known as blue-green... Read More